Healthcare
ADAllen Pharma
United Kingdom
Company profile
About the company
ADAllen Pharma sources and supplies licensed comparator medicines, biosimilars and ancillary products for clinical trials. It supports pharmaceutical companies, contract research organisations and other trial sponsors with project management, cold-chain storage, packaging and international logistics. The UK business coordinates clinical-supply programmes that move medicines and supporting materials to research sites in multiple countries.
Public claim
What the listing records.
“ADAllen Pharma reports a 45 tCO2e independently quantified 2024 baseline and a reduction plan focused on electricity, procurement and transport emissions.”
Evidence note
The company's 2026 reporting page states that its GHG Protocol inventory was independently quantified and identifies Scope 3 logistics and purchased goods as the dominant sources.
Source type: Company website